CHANGE IN HEALTHCARE UTILIZATION AND COSTS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD) INITIATING ADJUNCTIVE THERAPY WITH SECOND-GENERATION ANTIPSYCHOTICS (SGAS)

被引：1
|
作者：
Hagiwara, M. [1 ]
Sun, S. X. [2 ]
Moynahan, A. [1 ]
Bornheimer, R. [1 ]
Oster, G. [1 ,3 ]
机构：
[1] PAI, Brookline, MA USA
[2] Forest Res Inst, Jersey City, NJ USA
[3] MINERVA Hlth Econ Network, Brookline, MA USA
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 03期
关键词：
D O I：
10.1016/j.jval.2015.03.697
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMH25
引用
收藏
页码：A119 / A119
页数：1
相关论文
共 50 条
  • [41] Comparative study of treatment continuation using second-generation antipsychotics in patients with schizophrenia or schizoaffective disorder
    Azekawa, Takaharu
    Ohashi, Shizuko
    Itami, Akira
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2011, 7 : 691 - 695
  • [42] Does the use of atypical antipsychotics as adjunctive therapy in depression result in cost savings? Comparing healthcare costs and utilization between second-line treatment options
    Hassan, Amany K.
    Farmer, Kevin C.
    Brahm, Nancy C.
    Keast, Shellie
    Nesser, Nancy
    Neas, Barbara R.
    [J]. JOURNAL OF MENTAL HEALTH, 2016, 25 (06) : 486 - 491
  • [43] RISK OF NEW ONSET TYPE II DM IN MDD PATIENTS RECEIVING SECOND-GENERATION ANTIPSYCHOTICS TREATMENT: A NATIONWIDE COHORT STUDY
    Lin, Chun-Yuan
    Wu, Yu-Hsin
    Wang, Hong-Song
    Chen, Ping-Kun
    Lin, Yuan-Fu
    Chien, I-Chia
    [J]. DEPRESSION AND ANXIETY, 2016, 33 (05) : 435 - 443
  • [44] Healthcare resource utilization of second-generation long-acting injectable antipsychotics in schizophrenia: risperidone versus paliperidone palmitate
    Joshi, Kruti
    Pan, Xiaoyun
    Wang, Rosa
    Yang, Erru
    Benson, Carmela
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (11) : 1873 - 1881
  • [45] Effect of augmented atypical antipsychotics on weight change in patients with major depressive disorder in a naturalistic setting
    Seo, Ho-Jun
    Jung, Young-Eun
    Woo, Young Sup
    Jun, Tae-Youn
    Chae, Jeong-Ho
    Bahk, Won-Myong
    [J]. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2009, 24 (02) : 135 - 143
  • [46] Effect of augmented atypical antipsychotics on weight change in patients with major depressive disorder in a naturalistic setting
    Han, J. -H.
    Seo, H. -J.
    Jung, Y. -E.
    Woo, Y. S.
    Jun, T. -Y.
    Chae, J. -H.
    Bahk, W. -M.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 94 - 94
  • [47] Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics
    Correll, Christoph U.
    Frederickson, Anne M.
    Kane, John M.
    Manu, Peter
    [J]. BIPOLAR DISORDERS, 2008, 10 (07) : 788 - 797
  • [48] Effects of adjunctive aripiprazole in patients with major depressive disorder with inadequate response to standard antidepressant therapy
    Lee, J. S.
    Kim, S. G.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S865 - S866
  • [49] An open clinical trial of adjunctive therapy with aripiprazole in patients with partial remission of major depressive disorder
    Kim, H.
    Lee, K. J.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S410 - S410
  • [50] Aripiprazole as Adjunctive Therapy for Patients with Major Depressive Disorder Overview and Implications of Clinical Trial Data
    Pae, Chi-Un
    Forbes, Andy
    Patkar, Ashwin A.
    [J]. CNS DRUGS, 2011, 25 (02) : 109 - 127
12345